IMMUTEP Ltd (IMMP) shareholders
IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30
$3.26−0.14 (-4.12%)
Close on Nov 17, 2026Market cap $24.02MP/E –Yield –
Ownership
Who owns Immutep's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Marc Voigt | See Remarks, Director | 85,700 | Apr 13, 2026 |
| Deanne Diem Miller | Chief Operating Officer | 2,867,305 | Apr 13, 2026 |
| Christian Mueller | Chief Development Officer | 3,774,048 | Apr 1, 2026 |
| Stephan Karel Gerard Winckels | Chief Medical Officer | 92,935 | Apr 1, 2026 |
| Elisabeth Amanda Boyce | Director | 423,288 | Apr 16, 2026 |
| Pete A. Meyers | Director | 4,052,173 | Apr 7, 2026 |
| Frederic Joseph Daniel Triebel | Director | 170,610 | Apr 1, 2026 |
| Russell J. Howard | Director | 1,717,977 | Apr 1, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
2.4
At 0M shares a day
Change since last report
-1.1%
From 0M shares
Short volume, 20 days
59.4%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Immutep's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,787 shares on Aug 28, 2026 over the last 90 days.
See a number that looks wrong?